FFountain Life provides a membership-based health and wellness platform that helps high-net-worth clients optimize longevity and performance. It combines advanced diagnostics, biometric data analysis, DNA sequencing, and comprehensive medical screenings to create personalized care plans. Members gain ongoing access to data-driven insights and expert medical guidance from renowned professionals. The service works by collecting and analyzing biometric and genetic information, then using those results to tailor proactive health interventions and screenings through a guided plan. Compared to typical wellness offerings, Fountain Life pairs high-end medical expertise with a continuous, data-driven approach and a subscription model, aiming to deliver proactive, personalized health management. The company’s goal is to empower individuals to take control of their health to live longer, healthier lives.
Work here?Claim your company
Industries
Company Size
201-500
Company Stage
Series B
Total Funding
$100.1M
Headquarters
Orlando, FL
Founded
2019
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$100.1M
Above
Industry Average
Funded Over
3 Rounds
Industry standards
The Fountain at River Oaks: Fountain Life opens its fifth centre. When Fountain Life, backed by Peter Diamandis and Tony Robbins, opened its fifth American centre inside a Houston members' club, HUMANWARE was there to see a clinic built around screening for disease before symptoms appear Situated inside a private club as opposed to a typical medical district, Fountain Life's latest US-based centre sits on the ground floor of Park House in River Oaks, Houston, among the club's culinary rooms and cultural programming. Access to the clinic comes bundled into club membership, so patients encounter it as part of belonging rather than as a scheduled medical visit. The Houston centre is the second in Texas, opened on the strength of demand from Dallas, with Los Angeles and Miami to follow. A homecoming in cowboy boots. HUMANWARE was present for the opening, at a celebration that brought together the company's founders, its physicians and a circle of Houston's most committed advocates for proactive health. It was a homecoming of sorts. Fountain Life's CEO, Dr William Kapp, lived in the city for eight years, and marked the occasion in a pair of cowboy boots he rarely gets to wear. How Fountain Life began. Fountain Life was founded in 2020, born of a merger between William's Longevity Performance Center in Naples, Florida and Fountain Therapeutics - the venture backed by Peter Diamandis and Tony Robbins. Dr Robert Hariri, the stem-cell pioneer, completed the founding line-up. Five years on, the company has become one of the most recognisable names in a field that barely existed when it began. And as William puts it, when they started out, almost nobody was talking about longevity; now everybody is. One diagnostic day, 200GB of data. The procedure is straightforward, with a member arriving for a single diagnostic day, and leaving after having generated some 200GB of data about their own body: a whole-body MRI, a coronary scan, full genome sequencing, more than a hundred blood biomarkers and a microbiome analysis. The findings are read against the 12 hallmarks of ageing and interpreted with the help of Zori AI Medical Expert, the company's proprietary AI. The goal, here, is detection over reassurance. Fountain Life reports that in 14 per cent of seemingly healthy members, it finds something potentially life-altering - an early cancer, an aneurysm or a silent blockage in a major artery of the heart. Why conventional medicine looks too late. William, a former orthopaedic surgeon who once built hospitals, is direct about why conventional medicine so rarely looks for what is already there, but just not visible yet. The system, he explains, is designed to respond to symptoms, and the body is exceptionally good at hiding disease until it is late. He speaks from painful experience, recalling how his mother died of ovarian cancer caught too late - something that should have been picked up early and easily, had the right technology been available. What membership costs - and where the price is heading. Admittedly, membership is not cheap, with a comprehensive concierge programme running to around £18,000 ($23,5000) a year and a testing-led tier to roughly £7,400 ($10,000). William's ambition is to bring the price down as the underlying technology becomes more affordable and the data deepens (genome sequencing that once cost a fortune now costs a fraction, for instance); and, in time, to train other clinics in the Fountain Life method. Prevention above all else. Like Fountain Life, The HumanWare Project is built on the conviction that the future of health must be proactive, personalised and data-rich - and that the people who understand this first will be the ones leading what comes next. This could not have been clearer as The HumanWare Project sat in that room in River Oaks, at the opening of a clinic that prioritises prevention above all else. Borrowing a line from Mark Twain that doubles as the animating idea behind everything Fountain Life is trying to do, Peter's parting thought was this: "There are two important days in your life: The day you are born, and the day you find out why." | Useful to Know Peter, who sat with HUMANWARE at the opening, has spent decades arguing that medicine is heading towards a point where The HumanWare Project learn to slow ageing as well as reverse it - and that the point of a place like Fountain Life is to keep you healthy enough to reach the technologies and treatments that are coming. | | The Diagnostic Day The Fountain Life diagnostic day combines a whole-body and brain MRI, an advanced cardiac scan, full genome sequencing, microbiome analysis and 100+ blood biomarkers, interpreted with the company's Zori AI Medical Expert. Membership tiers run from testing-led access to a full concierge programme with an always-on care team. | | Fountain Life in Figures - Founded in 2020 by Peter Diamandis, Tony Robbins, Dr William Kapp and Dr Robert Hariri - Houston is Fountain Life's fifth US centre, joining Naples, Orlando, Dallas and Westchester, New York - More than 1,500 sqm (5,000 sq ft) inside Park House at River Oaks [EDITORIAL: figures do not reconcile - see flags] - Around 200GB of health data captured in a single diagnostic day - A potentially life-altering condition found in 14 per cent of seemingly healthy members - Membership from around £7,400 (10,000)to£18,000(23,500) per year - Los Angeles and Miami centres planned to follow | Key takeaways. 01. 02. 03. 04. Bonus content. Are you a forward-thinking investor looking to capitalise on the longevity revolution? A scientist seeking collaboration on breakthrough research? A health tech founder ready to scale your innovation? The HumanWare Circle connects the most influential minds driving human longevity - one network with unlimited human potential. Access exclusive investment opportunities, cutting-edge research insights, and partnerships that don't exist anywhere else. Join The HumanWare Circle and position yourself at the forefront of humanity's greatest transformation.
Fountain Life named Longevity Clinic of the Year. Fountain Life has been named Longevity Clinic of the Year 2026 by the Roundtable of Longevity Clinics, marking its second consecutive year receiving the award. The award was presented in conjunction with the Roundtable at the Buck Institute for Research on Aging in Novato, California. Its longitudinal dataset includes more than 15 billion clinical data points from over 8,000 members and reports measurable outcomes: 88% of members show early coronary plaque signs with 26% halting progression and 6% regressing; 51% of members with prediabetes return to normal blood sugar in an average of 1.2 years and 64% of members with diabetes improve; follow-up MRI confirms resolution in 52% of fatty liver cases; nearly one in four members show accelerated brain aging at baseline with 46% improving on follow-up; and early cancer signals are identified in up to 3.4% of members. Memberships combine AI-guided diagnostics, the Zori AI Medical Expert, restorative therapeutics and always-on care, with testing that can include full-body and brain MRI, coronary plaque analysis, whole genome sequencing, biological age profiling, more than 100 blood biomarkers, microbiome analysis, VO2 max testing and functional movement assessments, generating more than 150 GB of health data per member. Fountain Life operates centers in New York, Naples, Orlando, Dallas and Houston, with locations in Los Angeles and Miami planned.
Fountain Life has been named Longevity Clinic of the Year 2026 by the Roundtable of Longevity Clinics, the second year in a row it has won. Longevity medicine leaders and experts voted on the award, which was presented at the Buck Institute for Research on Aging in Novato, California. The company's dataset includes more than 15 billion clinical data points from over 8,000 members. Among its findings, 51% of members with prediabetes return to normal blood sugar levels in an average of 1.2 years, and follow-up MRI confirms resolution in 52% of fatty liver cases. Fountain Life, founded in 2020, combines diagnostics, ongoing health tracking, and personalised care guided by its Zori AI. It runs centres in New York, Naples, Orlando, Dallas, and Houston, with Los Angeles and Miami coming soon.
Celularity and Fountain Life have announced the availability of cenplacel-L, a placental-derived investigational cell therapy, for physician-directed use in Florida under newly enacted state legislation. The framework enables licensed physicians to administer certain unapproved cell therapies outside traditional FDA pathways, potentially serving as a model for broader market expansion. Cenplacel-L is an allogeneic cellular therapy developed by Celularity with demonstrated immunomodulatory and regenerative potential in clinical studies. The company maintains inventory at its FDA-registered, GMP-compliant manufacturing facility and is prepared to support investigational use under Florida law. Florida's legislation, effective July 2025, authorises licensed physicians to perform certain unapproved cell therapies within their scope of practice, subject to strict sourcing, manufacturing, accreditation and patient consent requirements. The therapy has not received FDA approval.
Impact Podcast with John Shegerian features special two-part, in-depth interview with Dr. Dawn Mussallem. Healthy Living and Longevity Thought Leader Shares Her Personal Inspirational Survival Story LOS ANGELES-(BUSINESS WIRE)-#cancer-Lifestyle medicine thought leader and Chief Medical Officer of Fountain Life Dr. Dawn Mussallem, DO, DipABLM, is the featured guest of a special two-part, in-depth conversation premiering this week on the Impact Podcast with John Shegerian. The show is hosted by Shegerian, Co-Founder and Chairman/CEO of ERI. Dr. Mussallem was appointed Chief Medical Officer of Fountain Life, a premier longevity company, in December 2025. Previously a renowned Mayo Clinic consultant in hematology/oncology and a double board-certified lifestyle medicine specialist, she now leads Fountain Life's efforts to advance AI-driven, proactive, and preventive health strategies. Her professional mission is deeply shaped by her own extraordinary health journey. She had a stage IV cancer diagnosis three months into medical school, followed by a life-restoring heart transplant in 2021. In a landmark achievement, she became the first person in the world to run a full marathon one year after a heart transplant, embodying the principles of recovery, regeneration, and peak performance that she teaches. In the Impact Podcast interview, Dr. Mussallem shares details of her powerful story of how she conquered a unique combination of challenges to get to where she is today. She also shares wisdom and professional insights on healthy living, nutrition, sleep and screenings that can help anyone live their best and healthiest life. "It was a tremendous honor to have Dawn, a true wellness icon and triumphant spirit on so many levels, on our show to share her incredible story and impactful healthy living advice," said Shegerian. "Our audience is sure to be inspired by and learn much from this captivating conversation." "Thanks so much to John and the Impact Podcast for having me on the show," said Dr. Mussallem. "And good luck to all of the Impact listeners. We're all in this journey of life together to elevate each other. So let's continue on that path of wellness." Impact Podcast guests are invited as thought leaders to share with listeners first-hand accounts of how they are able to help make the world a better place on a daily basis. The Impact Podcast with John Shegerian is available for listening on ImpactPodcast.com, Spotify, Apple Podcasts, Audible, Amazon Music, Youtube Music, Pandora, and as part of iHeartRadio's digital broadcast.
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
201-500
Company Stage
Series B
Total Funding
$100.1M
Headquarters
Orlando, FL
Founded
2019
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs